Isomalto-oligosaccharide.
A starch derived sugar chain your enzymes only partly break down. The part that gets past feeds gut bacteria into short chain fatty acids, and the rest is absorbed as glucose.
- Category
- Fiber
What Isomalto-oligosaccharide is, and what it does.
- Does it work
- It suits people who want a bulking syrup that also feeds gut bacteria. If you count carbohydrate closely, count part of it as sugar, because part of it is digested.
- How much to take
- No dose figure is on record. Start with a fraction of a serving and build up over a week or two, since gas comes from a large amount arriving all at once.
- Time to feel it
- Fermentation begins within hours of a serving reaching the colon. Changes in regularity and gut comfort usually settle in over the first one to two weeks.
- The first dose
- You may notice more gas or a gurgling gut on day one, especially with a full serving. Starting small keeps that mild.
- With regular use
- Weeks of daily use give your colon bacteria a steady fermentable supply, which shows up as short chain fatty acid production and steadier regularity.
- How well tolerated
- Well tolerated when built up gradually. Gas and bloating are the common complaint at higher intakes, so anyone with sensitive digestion should start at the low end.
- How it feels
- Mostly it just tastes mildly sweet, about half the sweetness of sugar. The honest sensation is gut activity: some rumbling early on that settles as bacteria adjust.
- The overlooked benefit
- Chain length decides everything. A batch rich in longer chains reaches the colon and behaves like fibre, while a short chain one is mostly digested higher up.
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
- Partial resistance to human digestive enzymesNarrative review
- Colonic fermentation to short chain fatty acidsRandomised trial
- Bowel regularityRandomised trial
- Bifidobacteria numbers in the gutRandomised trial
- Glucose contribution from the digested fractionRandomised trial
- Dose dependent gas and bloatingRandomised trial
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
IMO is used in protein bars as a bulk sweetener and binder that raises fibre content on the panel while keeping texture workable. The cited work compared the combined bar with a carbohydrate control, so the two ingredients cannot be separated. The pairing is a formulation choice with a performance comparison attached, not evidence of a nutrient interaction.
The two are fermented at different rates and in different regions of the colon, inulin more proximally and IMO variably depending on how much of it resists digestion. Blending them spreads fermentation across a longer stretch of bowel. The cited study was in animals, so read the transit finding as mechanistic support rather than a human outcome.
The alpha-1,6 bonds in IMO resist human pancreatic amylase but are accessible to several colonic bacteria including bifidobacteria. That is the whole basis of the synbiotic pairing. Note that a meaningful fraction of commercial IMO is digestible in the small intestine, so how much substrate actually arrives depends on the specific product's degree of polymerisation.
Resistant starch ferments slowly and reaches the distal colon, while the fermentable share of IMO is used earlier. Combining them gives a broader fermentation profile than either alone. This is substrate reasoning from established carbohydrate chemistry, not a tested combination in people.
Psyllium is viscous and largely unfermented, so it works by holding water and adding stool bulk. IMO's fermentable fraction works by feeding bacteria. Combining a bulking fibre with a fermentable one covers both routes, and it can moderate the gas that a purely fermentable fibre produces.
Brush-border alpha-glucosidases hydrolyse a substantial share of commercial IMO before it reaches the colon, which is why analytical fibre content and physiological fibre behaviour diverge for this ingredient. Added glucosidase-containing enzyme blends push that share higher. The practical effect is less material arriving as fermentable substrate and more absorbed as glucose.
IMO is used as the carbohydrate half of synbiotic formulas, supplying substrate to the delivered strain. The pairing is common in commercial products and reviewed in the cited source. How much benefit depends on the product's actual non-digestible fraction, which varies widely between suppliers.
Because a share of IMO is hydrolysed to glucose in the small intestine, products marketed as low-glycaemic fibre can still raise blood glucose more than the label implies. Anyone tracking glucose response should count that fraction. The relevant caution here is about IMO itself rather than any true interaction with chromium.
Nothing specific on file for Isomalto-oligosaccharide. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Isomalto-oligosaccharide actually does.
These are chains of glucose linked in a way that our main starch-digesting enzyme handles poorly compared with the links found in regular starch.
Enzymes in the small intestine actually break down a good chunk of commercial IMO into glucose, so a meaningful portion gets absorbed rather than reaching the colon, meaning IMO's fiber value on paper overstates how it actually behaves in the body.
The part that resists digestion in the small intestine gets fermented by colon bacteria into short-chain fatty acids, plus hydrogen and carbon dioxide gas.
Quick fermentation of these sugars in the colon produces gas, which is the mechanical reason for the bloating some people notice at higher doses, and why it's often introduced gradually.
Where Isomalto-oligosaccharide comes from.
It starts as ordinary starch, usually corn or tapioca. Enzymes chop it into small sugar chains, then a second enzyme rewires the links into a shape human digestive enzymes handle poorly. The result is cleaned up and sold as a syrup or a powder.
The same molecule is reached more than one way. Which route a given product used is a manufacturing choice, and the finished compound is the same either way.
Corn, tapioca, rice or potato starch, chosen mostly for supply, cost and label positioning.
Alpha-amylase breaks the starch into shorter chains, then beta-amylase or pullulanase yields a maltose-rich hydrolysate.
Transglucosidase, typically from Aspergillus niger, moves glucose units from alpha-1,4 to alpha-1,6 linkages, producing isomaltose, panose, isomaltotriose and longer oligomers.
Carbon treatment and ion exchange remove colour, protein residues and salts.
Simulated moving bed chromatography strips mono- and disaccharides to raise the non-digestible share, used only for higher-grade material.
Evaporated to syrup at a stated solids content or spray-dried to powder, then assayed for oligosaccharide profile.
Getting Isomalto-oligosaccharide from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- A food bar with whey protein and isomalto-oligosaccharides was compared with a carbohydrate bar on performance and metabolic measures.Randomised trial. Grubic TJ et al., 2019 (Journal of the International Society of Sports Nutrition). PMID 31409363 ↗
- Inulin and isomalto-oligosaccharide together improved measures of gut motility and transit in the animals studied.Animal study. Yu X et al., 2021 (Journal of Animal Science). PMID 34487146 ↗
- A review of oligosaccharide prebiotics in functional foods, covering production routes, applications and the gap between analytical and physiological fibre.Narrative review. Sandra KS et al., 2026 (3 Biotech). PMID 42261381 ↗
- A review of cereal-derived xylo- and malto-oligosaccharides as prebiotics, covering structure, production and fermentation behaviour.Narrative review. Kostanova A et al., 2026 (Frontiers in Microbiology). PMID 41939720 ↗
- A Cochrane review of prebiotics in a specific patient group, with oligosaccharide prebiotics named among the interventions considered.Systematic review. Williams NC et al., 2023 (Cochrane Database of Systematic Reviews). PMID 37753791 ↗
- A review of prebiotic oligosaccharides as growth promoters, summarising fermentation and gut effects in the species studied.Narrative review. Abd El-Aziz AH et al., 2025 (Journal of Animal Physiology and Animal Nutrition). PMID 40001202 ↗
- Prebiotic-fed animals showed changes in growth, immune measures and gene expression relative to controls.Animal study. Abd El-Aziz AH et al., 2022 (Animal Biotechnology). PMID 32734820 ↗
- A review of prebiotics, probiotics and synbiotics in livestock gut health, naming oligosaccharide prebiotics among the agents covered.Narrative review. Yue T et al., 2025 (Metabolites). PMID 40710579 ↗
These are the studies our verdict leans on, chosen from the 8 we read for Isomalto-oligosaccharide. The full linked list is below.
The studies, linked.
2 sources behind our Isomalto-oligosaccharide verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- ClinicalTrials.gov ↗
- Clinical trialPre-meal High-performance Inulin Supplementation Reduce Post-prandial Glycaemic Response in Healthy Non Diabetic Subjects : a Repeated Single-arm Clinical TrialClinicalTrials.gov ↗8 participants, Completed
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.